This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
About
Fleur O’Hare
Unit Manager – Retinal Gene Therapy
Fleur O’Hare is a clinician-researcher managing projects at CERA that focus on inherited retinal diseases and accessible eye health information.
Fleur O’Hare
Unit Manager – Retinal Gene Therapy
PhD Candidate MPhil (Med) B.Orth (Hons)
Fleur O’Hare is an orthoptist with a background in medical research and public health. She currently works within CERA’s Retinal Gene Therapy Research Unit. Fleur is also the Senior Research Manager for the Vision Optimisation Group at the University of Melbourne.
Her early research work focused on understanding the relationship between the senses involving vision, hearing and smell perception. Since then, Fleur’s research areas have spanned into patient support and education, low vision assessment and vision restoration therapies such as the Bionic Eye and retinal gene therapy.
Fleur has been involved in clinical trial coordination and research management at CERA for many years. One of her current projects is looking at how the experience and engagement with research can be improved. This work is focused on ensuring that information about research is provided in varied accessible formats.
Fleur is passionate about ensuring that information is provided in ways that are easy to read and understand, and in a language that suits the individual. She is partnering with consumers and stakeholders to make sure information formats support informed decision making.
Find out more about the Meeting Access and Inclusion Needs (MAIN) project.
Current projects
Selected publications
Key collaborators
Funding and support
Current projects
- Natural history study of inherited retinal diseases: observational study collecting and analysing information to characterise patterns of disease over time
- Neuroprotection therapy for patients with Usher Syndrome: clinical treatment trial investigating the safety and efficacy of this therapy in patients with Usher Syndrome
- Gene therapy for select inherited retinal diseases such as X-linked forms of inherited disease
- Gene therapy for age-related macular degeneration associated with geographic atrophy (dry AMD)
Selected publications
O’Hare F, Edwards TE, Hu M et al. An Optometrist’s Guide to the Top Candidate Inherited Retinal Diseases for Gene Therapy. Accepted for publication in Clinical and Experimental Optometry October 2020.
Hu M, Edwards TE, O’Hare F et al. Gene therapy for inherited retinal diseases: progress and possibilities. Accepted for publication in Clinical and Experimental Optometry November 2020.
Bentley SA, O’Hare F, Murphy GC et al. Psychosocial Assessment of Potential Retinal Prosthesis Recipients. Clinical & Experimental Optometry. 2019; 102(5): 506-512.
O’Hare F, Flanagan Z, Nelson M et al. Comparing two methods for delivering clinical trial information to older adults; singular versus stepped approach. Submitted to Clinical Trials Journal July 2018; 15(6): 610-615).
See more publications
Key collaborators
- Dr Lauren Ayton – Vision Optimisation Unit, Departments of Optometry and Vision Sciences and Surgery (Ophthalmology).
Funding and support
Thank you to the following organisations for their support:
- NHMRC
- CASS Foundation
- University of Melbourne
Contact Fleur O’Hare
Leave a direct enquiry for CERA below!
Please note: Unfortunately we are not able to provide individual medical advice over email.
